Stay updated on Tivozanib vs Sorafenib in Refractory RCC Clinical Trial

Sign up to get notified when there's something new on the Tivozanib vs Sorafenib in Refractory RCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tivozanib vs Sorafenib in Refractory RCC Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    The site revision identifier in the footer changed from v3.7.0 to v3.7.1; the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-06T19:47:21.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    Access to the study page now shows a 403 Forbidden error instead of the study record, effectively blocking the main content while the site chrome remains visible.
    Difference
    17%
    Check dated 2026-09-22T20:50:50.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.6.6 to v3.7.0, indicating a routine update to the site or document version.
    Difference
    0.0%
    Check dated 2026-09-15T20:35:52.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    The page footer now displays Revision: v3.6.6, replacing the previous Revision: v3.6.5.
    Difference
    0.0%
    Check dated 2026-09-01T18:20:15.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    The page's revision metadata was updated from v3.6.4 to v3.6.5, indicating a minor update to the page.
    Difference
    0.0%
    Check dated 2026-08-11T14:40:13.000Z thumbnail image
  8. Check
    81 days ago
    Change Detected
    Summary
    The page’s revision tag was updated to a newer version, indicating a small update to the study record’s metadata. This does not modify the study details or visible content.
    Difference
    0.0%
    Check dated 2026-07-28T04:53:24.000Z thumbnail image

Stay in the know with updates to Tivozanib vs Sorafenib in Refractory RCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tivozanib vs Sorafenib in Refractory RCC Clinical Trial page.